AGPAT2 Antikörper

Produktnummer ABIN7262361

Produktdetails anti-AGPAT2 Antikörper

Target: AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser AGPAT2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF)

Produktmerkmale: Polyclonal Antibody

Aufreinigung: Affinity purification

Immunogen: Recombinant fusion protein of human AGPAT2 (NP_006403.2).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:500-1:2000 IF 1:50-1:100

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu AGPAT2

Target: AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))

Andere Bezeichnung: AGPAT2 (AGPAT2 Produkte)

Synonyme: AGPAT2 antikoerper, zgc:153984 antikoerper, 1-agpat2 antikoerper, bscl antikoerper, bscl1 antikoerper, lpaab antikoerper, lpaat-beta antikoerper, 1-AGPAT2 antikoerper, BSCL antikoerper, BSCL1 antikoerper, LPAAB antikoerper, LPAAT-beta antikoerper, 2510002J07Rik antikoerper, AV000834 antikoerper, 1-acylglycerol-3-phosphate O-acyltransferase 2 antikoerper, 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) antikoerper, AGPAT2 antikoerper, agpat2 antikoerper, Agpat2 antikoerper

Hintergrund: This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.

Molekulargewicht:

Observed_MW: 31 kDa

Calculated_MW: 27 kDa/30 kDa

Gen-ID: 10555

UniProt: O15120